lupsma vs cabazitaxel in metastatic castration-resistant prostate cancer progressing after docet...
Published 4 years ago • 144 plays • Length 5:59Download video MP4
Download video MP3
Similar videos
-
5:51
lupsma vs cabazitaxel for metastatic castration-resistant prostate cancer
-
2:56
therap: lupsma versus cabazitaxel for prostate cancer
-
11:23
therap study: lu-psma vs. cabazitaxel #asco20 #anzup
-
4:34
card: cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer
-
8:11
asco: lupsma vs cabazitaxel for castration-resistant prostate cancer
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc
-
4:08
lu-177 psma-617 versus vs cabazitaxel: therap trial @ snmmi 2021
-
10:28
anzup therap study (lu-177 psma-617 vs. cabazitaxel): overall survival after 3 years follow-up
-
1:37
cabazitaxel rechallenge in patients with metastatic castration resistant prostate cancer
-
10:47
therap trial
-
0:45
treatment sequencing for metastatic castration-resistant prostate cancer
-
6:24
phase iii study of lutetium-177-psma-617 in patients with metastatic castration-resistant prosta...
-
2:46
upfrontpsma trial: 177lu-psma-617 and docetaxel in mhnpc
-
11:07
phase 3 vision study of 177lupsma 617 for metastatic castration-resistant prostate cancer
-
1:17
prince: 177lu-psma-617 and pembrolizumab in prostate cancer
-
3:41
177lu-psma-617 vs. cabazitaxel for mcrpc
-
6:45
177lu-psma-617 for prostate cancer: therap, vision, upfrontpsma and lutectomy
-
7:09
cabazitaxel use in metastatic prostate cancer
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer